Kelly Lawrence W & Associates Inc Viatris Inc Transaction History
Kelly Lawrence W & Associates Inc
- $395 Million
- Q1 2025
A detailed history of Kelly Lawrence W & Associates Inc transactions in Viatris Inc stock. As of the latest transaction made, Kelly Lawrence W & Associates Inc holds 2,244 shares of VTRS stock, worth $21,766. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,244
Previous 2,430
7.65%
Holding current value
$21,766
Previous $30,000
36.67%
% of portfolio
0.0%
Previous 0.01%
Shares
12 transactions
Others Institutions Holding VTRS
# of Institutions
1,120Shares Held
941MCall Options Held
4.05MPut Options Held
2.65M-
Vanguard Group Inc Valley Forge, PA145MShares$1.4 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$899 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD74.5MShares$722 Million0.08% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az66.4MShares$644 Million3.26% of portfolio
-
State Street Corp Boston, MA61.5MShares$596 Million0.02% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $11.8B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...